Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Lancet
    December 2018
  1. LEVY A, Chargari C, Deutsch E, Rivera S, et al
    Concerns about cardiotoxicity in the HERA trial.
    Lancet. 2018;390:2767.
    >> Share

  2. CAMERON DA, Gelber RD, Procter M, Suter T, et al
    Concerns about cardiotoxicity in the HERA trial - Authors' reply.
    Lancet. 2018;390:2767-2768.
    >> Share

    February 2018
  3. MCPHERSON K, Al Waheidi S
    The overestimation and the inappropriate promotion of the benefits of mammographic screening in breast cancer research and interventions in the Gaza Strip.
    Lancet. 2018;391 Suppl 2:S21.
    >> Share

    January 2018
  4. COLES CE, Haviland JS, Kirby AM, Titley J, et al
    Targeted radiotherapy for early breast cancer - Authors' reply.
    Lancet. 2018;391:27-28.
    >> Share

  5. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Targeted radiotherapy for early breast cancer.
    Lancet. 2018;391:26-27.
    >> Share

    August 2017
  6. MAMOUNAS EP, Kuehn T, Rutgers EJT, von Minckwitz G, et al
    Current approach of the axilla in patients with early-stage breast cancer.
    Lancet. 2017 Aug 14. pii: S0140-6736(17)31451.
    >> Share

  7. COLES CE, Griffin CL, Kirby AM, Titley J, et al
    Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31145.
    >> Share

  8. JAGSI R
    Early-stage breast cancer: falling risks and emerging options.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31599.
    >> Share

    June 2017
  9. THE LANCET
    Breast cancer targeted therapy: successes and challenges.
    Lancet. 2017;389:2350.
    >> Share

    February 2017
  10. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    >> Share

  11. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    >> Share

    January 2017
  12. THE LANCET
    Trastuzumab emtansine and cost-based decision making.
    Lancet. 2017;389:2.
    >> Share

    November 2016
  13. CRISTOFANILLI M
    Metastatic breast cancer: focus on endocrine sensitivity.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32418.
    >> Share

  14. ROBERTSON JF, Bondarenko IM, Trishkina E, Dvorkin M, et al
    Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32389.
    >> Share

  15. HARBECK N, Gnant M
    Breast cancer.
    Lancet. 2016 Nov 16. pii: S0140-6736(16)31891.
    >> Share

    September 2016
  16. THE LANCET
    Balancing the benefits and risks of choice.
    Lancet. 2016;388:1129.
    >> Share

    June 2016
  17. OHUCHI N, Suzuki A, Yamamoto S, Kuriyama S, et al
    Adjunctive ultrasonography for breast cancer screening - Authors' reply.
    Lancet. 2016;387:2381-2.
    >> Share

  18. AUTIER P, Boniol M
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380.
    >> Share

  19. FUJITA T
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380-1.
    >> Share

  20. DALE A, Slade E, Heneghan C
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2379-80.
    >> Share

    May 2016
  21. BERNSTEIN M
    Intraoperative radiation therapy for breast cancer: a patient's view.
    Lancet. 2016;387:1904-5.
    >> Share

    April 2016
  22. STRNAD V, Uter W, Polgar C
    Partial breast irradiation and the GEC-ESTRO trial - Authors' reply.
    Lancet. 2016;387:1718-9.
    >> Share

  23. VICINI F, Shah C, Arthur D, Khan A, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717-8.
    >> Share

  24. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016